Henlius Reports Stable Share Capital for May 2026; Minor Lapses in Option and RSU Pools

Bulletin Express06-03

Shanghai Henlius Biotech, Inc. filed its May 2026 monthly return, confirming that the company’s share structure remained unchanged during the period.

Total authorised and registered share capital held steady at RMB 543.49 million, comprising 346.07 million H-shares listed in Hong Kong and 197.42 million unlisted ordinary shares, each with a par value of RMB 1.

Issued share capital mirrored the authorised total—346.07 million H-shares and 197.42 million unlisted shares—with zero treasury shares outstanding. Henlius also reaffirmed compliance with Hong Kong’s public-float requirement, maintaining the initial prescribed threshold of 18.77%.

Equity incentive activity was limited. Under the 2025 H Share Option Scheme, 10,000 options lapsed, trimming outstanding options to 7.71 million. These options could give rise to 28.04 million new H-shares if fully exercised; no shares were issued and no funds were raised during the month.

The 2025 H Share RSU Scheme recorded a lapse of 10,000 RSUs, leaving 7.73 million RSUs outstanding at month-end. No restricted shares were vested or issued.

With no share issuances, buybacks, or treasury movements, Henlius closed May 2026 with an unchanged total of 543.49 million issued shares, underscoring stable capital structure throughout the month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1147358861?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-03 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147358861","market":"us","top_or_hot":-1,"title":"Henlius Reports Stable Share Capital for May 2026; Minor Lapses in Option and RSU Pools","media":"Bulletin Express","content":"<p>Shanghai Henlius Biotech, Inc. filed its May 2026 monthly return, confirming that the company’s share structure remained unchanged during the period.</p>\n<p>Total authorised and registered share capital held steady at RMB 543.49 million, comprising 346.07 million H-shares listed in Hong Kong and 197.42 million unlisted ordinary shares, each with a par value of RMB 1.</p>\n<p>Issued share capital mirrored the authorised total—346.07 million H-shares and 197.42 million unlisted shares—with zero treasury shares outstanding. Henlius also reaffirmed compliance with Hong Kong’s public-float requirement, maintaining the initial prescribed threshold of 18.77%.</p>\n<p>Equity incentive activity was limited. Under the 2025 H Share Option Scheme, 10,000 options lapsed, trimming outstanding options to 7.71 million. These options could give rise to 28.04 million new H-shares if fully exercised; no shares were issued and no funds were raised during the month.</p>\n<p>The 2025 H Share RSU Scheme recorded a lapse of 10,000 RSUs, leaving 7.73 million RSUs outstanding at month-end. No restricted shares were vested or issued.</p>\n<p>With no share issuances, buybacks, or treasury movements, Henlius closed May 2026 with an unchanged total of 543.49 million issued shares, underscoring stable capital structure throughout the month.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Henlius Reports Stable Share Capital for May 2026; Minor Lapses in Option and RSU Pools</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHenlius Reports Stable Share Capital for May 2026; Minor Lapses in Option and RSU Pools\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-03 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Henlius Biotech, Inc. filed its May 2026 monthly return, confirming that the company’s share structure remained unchanged during the period.</p>\n<p>Total authorised and registered share capital held steady at RMB 543.49 million, comprising 346.07 million H-shares listed in Hong Kong and 197.42 million unlisted ordinary shares, each with a par value of RMB 1.</p>\n<p>Issued share capital mirrored the authorised total—346.07 million H-shares and 197.42 million unlisted shares—with zero treasury shares outstanding. Henlius also reaffirmed compliance with Hong Kong’s public-float requirement, maintaining the initial prescribed threshold of 18.77%.</p>\n<p>Equity incentive activity was limited. Under the 2025 H Share Option Scheme, 10,000 options lapsed, trimming outstanding options to 7.71 million. These options could give rise to 28.04 million new H-shares if fully exercised; no shares were issued and no funds were raised during the month.</p>\n<p>The 2025 H Share RSU Scheme recorded a lapse of 10,000 RSUs, leaving 7.73 million RSUs outstanding at month-end. No restricted shares were vested or issued.</p>\n<p>With no share issuances, buybacks, or treasury movements, Henlius closed May 2026 with an unchanged total of 543.49 million issued shares, underscoring stable capital structure throughout the month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02696","symbol_name":"复宏汉霖","start_time":0,"source_url":"","article_id":"1147358861","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147358861","pubTimestamp":1780477520,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Henlius Biotech, Inc. filed its May 2026 monthly return, confirming that the company’s share structure remained unchanged during the period. Total authorised and registered share capital...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02696":"复宏汉霖"},"translate_title":"复宏汉霖报告2026年5月股本稳定；购股权及受限制股份单位池出现轻微失误","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02696":1},"content_text":"Shanghai Henlius Biotech, Inc. filed its May 2026 monthly return, confirming that the company’s share structure remained unchanged during the period.\nTotal authorised and registered share capital held steady at RMB 543.49 million, comprising 346.07 million H-shares listed in Hong Kong and 197.42 million unlisted ordinary shares, each with a par value of RMB 1.\nIssued share capital mirrored the authorised total—346.07 million H-shares and 197.42 million unlisted shares—with zero treasury shares outstanding. Henlius also reaffirmed compliance with Hong Kong’s public-float requirement, maintaining the initial prescribed threshold of 18.77%.\nEquity incentive activity was limited. Under the 2025 H Share Option Scheme, 10,000 options lapsed, trimming outstanding options to 7.71 million. These options could give rise to 28.04 million new H-shares if fully exercised; no shares were issued and no funds were raised during the month.\nThe 2025 H Share RSU Scheme recorded a lapse of 10,000 RSUs, leaving 7.73 million RSUs outstanding at month-end. No restricted shares were vested or issued.\nWith no share issuances, buybacks, or treasury movements, Henlius closed May 2026 with an unchanged total of 543.49 million issued shares, underscoring stable capital structure throughout the month.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1147358861","isCrawlerRequest":true}